AMRN

#3363
Amarin Corp Plc
14.2000 USD
+1.72%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
14.2000
14.4200
Faixa anual
13.5100
17.0000
Mudança diária
+1.72%
Mudança mensal
-1.73%
Mudança em 6 meses
-8.74%
Mudança anual
-8.74%
Fechamento anterior
13.9600
Abrir
14.2500
Mínimo
14.2000
High
14.4200
Volume
11
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

Amarin Corporation plc - American Depositary Shares, each repre

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid. In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza.

Notícias